Robert Torray - Torray Investment Partners
Holding/activity history for Novo Nordisk A S (NVO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2012 Q4 | 0 | 0.00 | Sell 100.00% | 0.55 | SEC | ||
| 2012 Q3 | 15,015 | 0.55 | Add 11.26% | 0.06 | $157.84 | $2,370,000 | SEC |
| 2012 Q2 | 13,495 | 0.47 | Add 0.40% | <0.01 | $145.31 | $1,961,000 | SEC |
| 2012 Q1 | 13,441 | 0.43 | Reduce 18.12% | 0.09 | $138.68 | $1,864,000 | SEC |
| 2011 Q4 | 16,416 | 0.47 | Add 0.92% | <0.01 | $115.25 | $1,892,000 | SEC |
| 2011 Q3 | 16,266 | 0.45 | Add 3.24% | 0.01 | $99.53 | $1,619,000 | SEC |
| 2011 Q2 | 15,755 | 0.47 | Reduce 2.67% | 0.01 | $125.29 | $1,974,000 | SEC |
| 2011 Q1 | 16,187 | 0.44 | Reduce 15.54% | 0.08 | $125.22 | $2,027,000 | SEC |
| 2010 Q4 | 19,165 | 0.49 | Reduce 22.06% | 0.13 | $112,570.00 | $2,157,404,000 | SEC |
| 2010 Q3 | 24,590 | 0.58 | Buy | 0.58 | $98,440.02 | $2,420,640,000 | SEC |